CN113088485A - 斑马鱼成骨细胞体外培养方法 - Google Patents
斑马鱼成骨细胞体外培养方法 Download PDFInfo
- Publication number
- CN113088485A CN113088485A CN202110520788.9A CN202110520788A CN113088485A CN 113088485 A CN113088485 A CN 113088485A CN 202110520788 A CN202110520788 A CN 202110520788A CN 113088485 A CN113088485 A CN 113088485A
- Authority
- CN
- China
- Prior art keywords
- zebra fish
- cells
- osteoblasts
- culture
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000252212 Danio rerio Species 0.000 title claims abstract description 97
- 210000000963 osteoblast Anatomy 0.000 title claims abstract description 66
- 238000000338 in vitro Methods 0.000 title claims abstract description 15
- 238000012136 culture method Methods 0.000 title claims abstract description 10
- 210000004027 cell Anatomy 0.000 claims abstract description 108
- 210000001519 tissue Anatomy 0.000 claims abstract description 23
- 238000012258 culturing Methods 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 16
- 108010019160 Pancreatin Proteins 0.000 claims abstract description 12
- 229940055695 pancreatin Drugs 0.000 claims abstract description 12
- 241000251468 Actinopterygii Species 0.000 claims abstract description 10
- 230000000249 desinfective effect Effects 0.000 claims abstract description 6
- 238000004113 cell culture Methods 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 42
- 239000001963 growth medium Substances 0.000 claims description 36
- 229960005322 streptomycin Drugs 0.000 claims description 21
- 210000002966 serum Anatomy 0.000 claims description 19
- 241000252233 Cyprinus carpio Species 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 14
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 12
- 239000012894 fetal calf serum Substances 0.000 claims description 12
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 10
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 10
- 230000029087 digestion Effects 0.000 claims description 10
- 230000008014 freezing Effects 0.000 claims description 10
- 238000007710 freezing Methods 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 9
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 9
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 8
- 229930182566 Gentamicin Natural products 0.000 claims description 8
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 8
- 229940116977 epidermal growth factor Drugs 0.000 claims description 8
- 229960002518 gentamicin Drugs 0.000 claims description 8
- 210000003205 muscle Anatomy 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 238000005520 cutting process Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 5
- 239000011550 stock solution Substances 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 210000002808 connective tissue Anatomy 0.000 claims description 4
- 239000012286 potassium permanganate Substances 0.000 claims description 4
- 230000007910 cell fusion Effects 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 210000003555 cloaca Anatomy 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 2
- 238000003860 storage Methods 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 102000029816 Collagenase Human genes 0.000 abstract description 2
- 108060005980 Collagenase Proteins 0.000 abstract description 2
- 230000009471 action Effects 0.000 abstract description 2
- 229960002424 collagenase Drugs 0.000 abstract description 2
- 238000001976 enzyme digestion Methods 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 abstract description 2
- 238000010186 staining Methods 0.000 description 17
- 239000008055 phosphate buffer solution Substances 0.000 description 13
- 210000000349 chromosome Anatomy 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 102000004067 Osteocalcin Human genes 0.000 description 8
- 108090000573 Osteocalcin Proteins 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 7
- 102400001368 Epidermal growth factor Human genes 0.000 description 6
- 238000005138 cryopreservation Methods 0.000 description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000002230 centromere Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000008157 ELISA kit Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000014461 bone development Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000011164 ossification Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000031864 metaphase Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 101150014408 MINDY3 gene Proteins 0.000 description 1
- 101100005010 Mus musculus Ca8 gene Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 101150111716 ankrd1 gene Proteins 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000012534 cell culture medium component Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110520788.9A CN113088485B (zh) | 2021-05-13 | 2021-05-13 | 斑马鱼成骨细胞体外培养方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110520788.9A CN113088485B (zh) | 2021-05-13 | 2021-05-13 | 斑马鱼成骨细胞体外培养方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113088485A true CN113088485A (zh) | 2021-07-09 |
CN113088485B CN113088485B (zh) | 2024-04-05 |
Family
ID=76665342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110520788.9A Active CN113088485B (zh) | 2021-05-13 | 2021-05-13 | 斑马鱼成骨细胞体外培养方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113088485B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013117713A1 (en) * | 2012-02-08 | 2013-08-15 | Queen Mary & Westfield College, University Of London | Reversal of senescence |
CN104745526A (zh) * | 2015-04-22 | 2015-07-01 | 武汉大学 | 一种斑马鱼原代胚胎细胞体外分化为心肌细胞的新方法 |
CN104762252A (zh) * | 2015-04-27 | 2015-07-08 | 上海海洋大学 | 一种草金鱼腹鳍细胞系的构建方法 |
CN106978392A (zh) * | 2017-05-19 | 2017-07-25 | 华中农业大学 | 一种团头鲂骨组织细胞培养的方法 |
-
2021
- 2021-05-13 CN CN202110520788.9A patent/CN113088485B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013117713A1 (en) * | 2012-02-08 | 2013-08-15 | Queen Mary & Westfield College, University Of London | Reversal of senescence |
CN104745526A (zh) * | 2015-04-22 | 2015-07-01 | 武汉大学 | 一种斑马鱼原代胚胎细胞体外分化为心肌细胞的新方法 |
CN104762252A (zh) * | 2015-04-27 | 2015-07-08 | 上海海洋大学 | 一种草金鱼腹鳍细胞系的构建方法 |
CN106978392A (zh) * | 2017-05-19 | 2017-07-25 | 华中农业大学 | 一种团头鲂骨组织细胞培养的方法 |
Non-Patent Citations (26)
Title |
---|
PASQUALETTI S等: "Osteoblast and osteoclast behavior in zebrafish cultured scales", 《CELL TISSUE RES》 * |
PASQUALETTI S等: "Osteoblast and osteoclast behavior in zebrafish cultured scales", 《CELL TISSUE RES》, vol. 350, 7 June 2012 (2012-06-07), pages 69 - 75, XP035120405, DOI: 10.1007/s00441-012-1436-2 * |
ROSA, J等: "Serum-specific stimulation of proliferation and mineralization of fish bone-derived cells", J. APPL. ICHTHYOL, vol. 26, pages 253 * |
VIJAYAKUMAR P等: "Development of an in vitro cell system from zebrafish suitable to study bone cell differentiation and extracellular matrix mineralization", ZEBRAFISH, vol. 10, no. 4, pages 501 * |
关柠楠: "团头鲂runx2和osterix基因的克隆表达及骨组织细胞培养研究", 《中国学位论文全文数据》 * |
关柠楠: "团头鲂runx2和osterix基因的克隆表达及骨组织细胞培养研究", 《中国学位论文全文数据》, 18 January 2019 (2019-01-18) * |
关柠楠等: "团头鲂骨组织细胞系的建立及其生物学特性", 《水产学报》 * |
关柠楠等: "团头鲂骨组织细胞系的建立及其生物学特性", 《水产学报》, no. 04, 30 April 2018 (2018-04-30), pages 513 * |
关柠楠等: "团头鲂骨组织细胞系的建立及其生物学特性", 水产学报, vol. 42, no. 4, pages 513 * |
吴丹等: "骨髓间充质干细胞诱导成骨细胞模型中活化转录因子4基因的表达", 《中国组织工程研究》 * |
吴丹等: "骨髓间充质干细胞诱导成骨细胞模型中活化转录因子4基因的表达", 《中国组织工程研究》, vol. 18, 31 January 2014 (2014-01-31), pages 21 - 26 * |
孔祥婷等: "黄颡鱼吻端细胞培养研究", 《淡水渔业》 * |
孔祥婷等: "黄颡鱼吻端细胞培养研究", 《淡水渔业》, no. 02, 30 April 2009 (2009-04-30), pages 1 - 1 * |
孔祥婷等: "黄颡鱼吻端细胞培养研究", 淡水渔业, vol. 39, no. 2, pages 1 - 1 * |
张宏祥等: "斑石鲷肝脏细胞系的建立与鉴定", 《农业生物技术学报》 * |
张宏祥等: "斑石鲷肝脏细胞系的建立与鉴定", 《农业生物技术学报》, no. 02, 25 February 2020 (2020-02-25), pages 174 - 182 * |
张永忠等: "羌活鱼不同提取物血清对骨髓间充质干细胞影响的实验研究", 《中国中医骨伤科杂志》 * |
张永忠等: "羌活鱼不同提取物血清对骨髓间充质干细胞影响的实验研究", 《中国中医骨伤科杂志》, no. 04, 15 April 2015 (2015-04-15), pages 13 - 17 * |
杨建等: "肌间刺缺失对斑马鱼骨骼发育的影响", 《水生生物学报》 * |
杨建等: "肌间刺缺失对斑马鱼骨骼发育的影响", 《水生生物学报》, no. 03, 31 March 2020 (2020-03-31), pages 88 - 95 * |
王洁等: "快速老化SAMP6小鼠成骨细胞的体外培养鉴定和生长特性", 《温州医科大学学报》 * |
王洁等: "快速老化SAMP6小鼠成骨细胞的体外培养鉴定和生长特性", 《温州医科大学学报》, no. 10, 25 October 2018 (2018-10-25), pages 5 - 9 * |
胡孝丽等: "大鼠胎鼠成骨细胞的培养及初步鉴定", 《临床口腔医学杂志》 * |
胡孝丽等: "大鼠胎鼠成骨细胞的培养及初步鉴定", 《临床口腔医学杂志》, no. 04, 20 April 2016 (2016-04-20), pages 17 - 20 * |
鄂玲玲等: "改良大鼠下颌骨成骨细胞原代培养与鉴定", 《中华老年口腔医学杂志》 * |
鄂玲玲等: "改良大鼠下颌骨成骨细胞原代培养与鉴定", 《中华老年口腔医学杂志》, no. 04, 15 December 2007 (2007-12-15), pages 40 - 43 * |
Also Published As
Publication number | Publication date |
---|---|
CN113088485B (zh) | 2024-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | CRISPR/Cas9‐mediated sheep MSTN gene knockout and promote sSMSCs differentiation | |
CA2640644C (en) | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses | |
AU784580B2 (en) | Adipose-derived stem cells and lattices | |
Qu et al. | Osteogenic and adipogenic potential of porcine adipose mesenchymal stem cells | |
WO2021054449A1 (ja) | Lbm、cpc、opc、それらの調製方法及び品質管理方法、キット、移植材料並びに疾患モデル | |
US20040234972A1 (en) | Method for identifying and purifying smooth muscle progenitor cells | |
KR20060010820A (ko) | 내배엽계 줄기세포의 제조 | |
CN113462639B (zh) | 一种分离来源于人类诱导多能干细胞的成纤维细胞的方法及其应用 | |
CN113088485A (zh) | 斑马鱼成骨细胞体外培养方法 | |
WO2005108557A1 (ja) | 前駆間葉系幹細胞 | |
CN114480261B (zh) | 一种脐带来源骨骼干细胞的提取分离方法 | |
CN114276984B (zh) | 雌性生殖干细胞转分化至功能精子的方法及应用 | |
KR102331564B1 (ko) | 이종 동물 혈청이 첨가된 배지 없이 사람 하비갑개 유래 중간엽 줄기세포를 배양 및 분화시키는 방법 | |
CN114214272A (zh) | 一种诱导脐带间充质干细胞分化心肌细胞的方法、培养基及其应用 | |
AU2012227337B2 (en) | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses | |
CN114591915B (zh) | 一种大黄鱼体外诱导多能性干细胞的方法 | |
Nadri et al. | Isolation and expansion of mesenchymal stem cells from human conjunctival tissue | |
CN114085808B (zh) | 一种快速、持续获取vasa阳性类生殖细胞的方法 | |
WO2023032945A1 (ja) | 関節症治療剤、及び関節症治療剤の製造方法 | |
CN117757739A (zh) | 混合不同供体来源的组织建立间充质干细胞种子库的方法 | |
CN116064378A (zh) | 具有特异基因表达的人胚干细胞 | |
CN116814535A (zh) | 红鳍东方鲀精原干细胞系及其建立、鉴定和冻存方法 | |
CN115505573A (zh) | 一种迁移活力增强的基因工程间充质干细胞及在干细胞治疗、干细胞美容中的应用 | |
Foltz | Patient-Derived Induced Pluripotent Stem Cells for Modeling Splicing Factor Retinitis Pigmentosa in Retinal Pigmented Epithelial Cells and Retinal Organoids | |
CN117511859A (zh) | 诱导性多能干细胞来源的间充质干细胞及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Kuang Youyi Inventor after: Liu Tianqi Inventor after: Zheng Xianhu Inventor after: Tong Guangxiang Inventor after: Sun Zhipeng Inventor after: Yan Ting Inventor after: Xu Huan Inventor after: Dong Le Inventor after: Yang Xiaoxing Inventor before: Kuang Youyi Inventor before: Liu Tianqi Inventor before: Zheng Xianhu Inventor before: Tong Guangxiang Inventor before: Sun Zhipeng Inventor before: Yan Ting Inventor before: Xu Huan Inventor before: Dong Le Inventor before: Yang Xiaoxing |
|
GR01 | Patent grant | ||
GR01 | Patent grant |